《计算机应用》唯一官方网站 ›› 2024, Vol. 44 ›› Issue (3): 989-994.DOI: 10.11772/j.issn.1001-9081.2023070929

• 前沿与综合应用 • 上一篇    

自适应球形演化的药物-靶标相互作用预测方法

刘一迪1, 温自豪2, 任富香1, 李诗音1, 唐德玉1,3()   

  1. 1.广东药科大学 医药信息工程学院, 广州 510006
    2.莫纳什大学 信息技术学院, 澳大利亚 墨尔本 3800
    3.华南农业大学 数学与信息学院、软件学院, 广州 510640
  • 收稿日期:2023-07-12 修回日期:2023-09-19 接受日期:2023-09-20 发布日期:2023-10-26 出版日期:2024-03-10
  • 通讯作者: 唐德玉
  • 作者简介:刘一迪(1999—),女,河南驻马店人,硕士研究生,主要研究方向:药物发现、机器学习
    温自豪(1990—),男,广东广州人,博士研究生,主要研究方向:机器学习、人工智能
    任富香(1999—),女,山东日照人,硕士研究生,主要研究方向:疾病发现、机器学习
    李诗音(2000—),女,辽宁阜新人,硕士研究生,主要研究方向:疾病发现、机器学习;
  • 基金资助:
    国家自然科学基金资助项目(F060107);广东省自然科学基金资助项目(2020A1515010783)

Self-adaptive spherical evolution for prediction of drug target interaction

Yidi LIU1, Zihao WEN2, Fuxiang REN1, Shiyin LI1, Deyu TANG1,3()   

  1. 1.College of Medical Information Engineering,Guangdong Pharmaceutical University,Guangzhou Guangdong 510006,China
    2.Faculty of Information Technology,Monash University,Melbourne 3800,Australia
    3.College of Mathematics and Informatics,College of Software Engineering,South China Agricultural University,Guangzhou Guangdong 510640,China
  • Received:2023-07-12 Revised:2023-09-19 Accepted:2023-09-20 Online:2023-10-26 Published:2024-03-10
  • Contact: Deyu TANG
  • About author:LIU Yidi, born in 1999, M. S. candidate. Her research interests include drug discovery, machine learning.
    WEN Zihao, born in 1990, Ph. D. candidate. His research interests include machine learning, artificial intelligence.
    REN Fuxiang, born in 1999, M. S. candidate. Her research interests include disease discovery, machine learning.
    LI Shiyin, born in 2000, M. S. candidate. Her research interests include disease discovery, machine learning.
  • Supported by:
    National Natural Science Foundation of China(F060107);Natural Science Foundation of Guangdong Province(2020A1515010783)

摘要:

相较于传统药物的研发,药物-靶标的预测方法能够有效降低成本,加快研发进程,但是在实际应用中存在数据集平衡度低、预测精确率不高等问题。基于此,提出一种自适应球形演化的药物-靶标相互作用预测方法ASE-KELM(self-Adaptive Spherical Evolution based on Kernel Extreme Learning Machine)。该方法根据结构相似的药物与靶标更易存在相互作用的原理筛选出高置信度的负样本;并且为了解决球形演化算法易陷入局部最优的问题,利用搜索因子历史记忆的反馈机制及群大小线性递减的策略(LPSR),实现全局搜索和局部搜索的平衡,提高算法的寻优能力;然后利用自适应球形演化算法对核极限学习机(KELM)的参数进行优化。在基于黄金标准的数据集上将ASE-KELM与NetLapRLS(Network Laplacian Regularized Least Square)、BLM-NII(Bipartite Local Model with Neighbor-based Interaction profile Inferring)等算法进行对比,验证算法的性能。实验结果表明,在酶(E)、G-蛋白偶联受体(GPCR)、离子通道(IC)和核受体(NR)数据集中,ASE-KELM的ROC曲线下面积(AUC)与PR曲线下面积(AUPR)均优于对比算法;且基于DrugBank等数据库,ASE-KELM在预测新药物-靶标对的验证过程中表现良好。

关键词: 球形搜索, 核极限学习机, 药物-靶标相互作用, 药物发现, 自适应

Abstract:

Drug-target prediction method can effectively reduce costs and accelerate research process compared with traditional drug discovery. However, there are various challenges such as low balance of datasets and low precision of prediction in practical applications. Therefore, a drug-target interaction prediction method based on self-adaptive spherical evolution was proposed, namely ASE-KELM (self-Adaptive Spherical Evolution based on Kernel Extreme Learning Machine). By the method, negative samples with high confidence were selected based on the principle that drugs with similar structures are likely to interact with targets. And to solve the problem that spherical evolution algorithm tends to fall into local optima, the feedback mechanism of historical memory of search factors and Linear Population Size Reduction (LPSR) were used to balance global and local search, which improved the optimization ability of the algorithm. Then the parameters of Kernel Extreme Learning Machine (KELM) were optimized by the self-adaptive spherical evolution algorithm. ASE-KELM was compared with algorithms such as NetLapRLS (Network Laplacian Regularized Least Square) and BLM-NII (Bipartite Local Model with Neighbor-based Interaction profile Inferring) on gold standard based datasets to verify the performance of the algorithms. Experimental results show that ASE-KELM outperforms comparison algorithms in AUC (Area Under the receiver operating Characteristic curve) and AUPR (Area Under the Precision-Recall curve) for the Enzyme (E), G-Protein-Coupled Receptor (GPCR), Ion Channel (IC), and Nuclear Receptor (NR) datasets. And the effectiveness of ASE-KELM in predicting new drug-target pairs was validated on databases such as DrugBank.

Key words: spherical search, Kernel Extreme Learning Machine (KELM), drug-target interaction, drug discovery, self-adaptive

中图分类号: